Aurobindo shares spurt as USFDA lifts import alert

R. Y. Narayanan Coimbatore | Updated on March 12, 2018

Shares of Aurobindo Pharma Ltd have perked up by Rs 8.55 to Rs 139.20 (face value Re 1) on the BSE after the company informed that the USFDA has lifted the import alert for non-sterile products manufactured at one of its units in Hyderabad.

Quoting USFDA Web site, the company said that the import alert for non-sterile products produced at its unit-VI cephalosporin facility in Hyderabad I has been lifted, enabling resumption of exports of nine products to the US market.

Before the import alert was issued in February 2011, the unit had annual US sales of $33 million for the above mentioned products, APL said.

Published on March 28, 2013

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor